The main purpose of the vaccination against rubella is to prevent rubella from developing during pregnancy. If unprotected pregnant women become infected with rubella, there is a great danger that the newborn will also become ill. Severe malformations of the child’s brain, eyes or heart are often the result.

Vaccination for boys is also recommended because they can be a source of infection for unprotected pregnant women. In principle, all women should make sure in good time before pregnancy, that they have a sufficient amount of protective substances against rubella pathogens (so-called antibodies) in their blood. These protective substances can originate from a rubella infection or from a rubella vaccination.

The statutory health insurance funds cover the costs of this examination for their insured persons. In rare cases, rubella can cause encephalitis, which can lead to permanent brain damage.

Vaccination:
Live vaccine, preferably in combination with multiple vaccine MMR.

Who should be vaccinated?

  • All children
  • All women of childbearing age who are susceptible to rubella.
  • Adult women should be tested for rubella before vaccination. Pregnancy must be excluded at the time of vaccination. Pregnancy should also be prevented for 3 months after vaccination.

Time of vaccination:
First vaccination at the beginning of the second year of life. The second vaccination can already take place four weeks (= minimum distance) after the first vaccination and should be carried out as early as possible. If only one measles-mumps-rubella vaccination has preceded, then the second measles-mumps-rubella vaccination has to be completed for all children and adolescents – at the latest in the 11th to 15th year of life.
There is no age limit for a measles mumps rubella vaccination.

Frequent vaccination reactions:
Reddening, swelling at the vaccination site, occasional mild fever, headache, skin rash, swelling of lymph nodes, temporary joint pain in adults.